Role of Clinical Pharmacist in the healthcare management of Type II Diabetes mellitus patients
- Conditions
- Type 2 diabetes mellitus with other specified complications,
- Registration Number
- CTRI/2019/02/017516
- Brief Summary
The term diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both.
In 2017, there were 451 million (age 18-99 years) people with diabetes worldwide.
It is predicted that by 2030 diabetes mellitus may afflict up to 79.4 million individuals in India, while China (42.3 million) and the United States (30.3 million) will also see significant increases in those affected by the disease.
The total prevalence of diabetes in adults in India was 8.8 % in the year 2017.
Intensive lifestyle interventions involving a combination of diet and physical activity can delay or prevent diabetes among people at high risk.
Diabetes education and training is of critical importance and should be considered an integral part of diabetes prevention and care.
Available literature suggests that the management of diabetes in India is sub-optimal for the majority of patients. Only 40–50% of individuals achieve the target for glycemic control, while lower numbers achieve targets for blood pressure and lipid control.
Collaboration among physicians, nurses, dieticians, and pharmacists is required to ensure optimum patient care and adequate diabetes management.
International standards for diabetes care have recognized the crucial role of pharmacists in diabetes management.
There are lack of studies in India that analyze the attitudes and roles of pharmacist in diabetes management. The present study is an attempt in this direction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 200
- Known case of Type II Diabetes patients who attended the OP department.
- Patient whose HbA1C is ≥ 7 Patients of both genders >18 years of age.
- Patients who are type 1 diabetes, gestational diabetes and psychiatric illness.
- Patients who are not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes: Measurement at Baseline visit and at the end of 3 months Assessment of patient satisfaction of care Measurement at Baseline visit and at the end of 3 months Assessment of medication adherence by MARS scale Measurement at Baseline visit and at the end of 3 months
- Secondary Outcome Measures
Name Time Method Secondary outcomes: Improvement in laboratory parameters(Blood Pressure, Blood glucose, Lipid profile, S Creatinine)
Trial Locations
- Locations (1)
SRM Medical College Hospital and Research Centre
🇮🇳Kancheepuram, TAMIL NADU, India
SRM Medical College Hospital and Research Centre🇮🇳Kancheepuram, TAMIL NADU, IndiaPAULIN C VARGHESEPrincipal investigator9600054755angelopsr47@yahoo.com